Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical… For the past few months, Medicare officials have been inundated with impassioned… Read More...
Medicare proposes only covering Alzheimer’s drug Aduhelm for… Medicare officials are proposing to restrict coverage of a controversial Alzheimer's… Read More...
Medicare Will Not Fully Cover Aduhelm, the Controversial—and… Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer’s… Read More...
Medicare Proposes to Cover Aduhelm Only for Patients in Clinical… Medicare officials have decided that the federal health insurance program should only… Read More...
Why Biogen’s Alzheimer’s drug Aduhelm is so controversial The U.S. Food and Drug Administration's approval of Biogen's Alzheimer's drug Aduhelm… Read More...
Hopes and concerns over a new Alzheimer’s drug Not long ago, Joe Montminy was a hard-charging market research executive, wowing… Read More...
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got… Safety data from those trials was published Monday in the journal JAMA Neurology in a… Read More...